Research in Dr. Rasenick's lab concerns neurotransmitter response and responsiveness as mediated via G proteins. A unique feature of this research is the demonstration that elements of the cytoskeleton are capable of modifying neurotransmitter response (signal transduction). Further, it is suggested that neurotransmitters which ar not directly coupled to the adenylyl cyclase system might modify that enzyme by altering the interaction between tubulin (a cytoskeletal component) and G proteins on the synaptic membrane. Over the period covered by this award, the molecular facets of interaction between tubulin G proteins will be determined, and synthetic peptides will be made and used to block this interaction. Hopefully, such studies will describe the physiologic events resulting from the transfer of GTP from membrane tubulin to specific G proteins. Several planned collaborations involve using a photoaffinity GTP analog made in this laboratory (AAGTP) to explore unique signal-mediated activation of G proteins. Collaborations are also proposed to study structural aspects of tubulin-G protein interaction. These studies involve either chemical crosslinking or immunocytochemistry at the EM level. Finally, several collaborative studies are proposed to study tubulin-G protein interactions using molecular genetic techniques. Hopefully, a more thorough understanding of the contributions which elements of the cytoskeleton make to neuronal signal transduction will also elucidate certain mysteries of mental function and dysfunction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Scientist Development Award - Research (K02)
Project #
2K02MH000699-06
Application #
3070102
Study Section
Molecular, Cellular, and Developmental Neurobiology Review Committee (MCDN)
Project Start
1987-08-01
Project End
1997-08-31
Budget Start
1992-09-30
Budget End
1993-08-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Rasenick, M M; Chaney, K A; Chen, J (1996) G protein-mediated signal transduction as a target of antidepressant and antibipolar drug action: evidence from model systems. J Clin Psychiatry 57 Suppl 13:49-55;discussion 56-8
Chen, J; Rasenick, M M (1995) Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase. J Neurochem 64:724-32
Chen, J; Rasenick, M M (1995) Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J Pharmacol Exp Ther 275:509-17
Rasenick, M M; Watanabe, M; Lazarevic, M B et al. (1994) Synthetic peptides as probes for G protein function. Carboxyl-terminal G alpha s peptides mimic Gs and evoke high affinity agonist binding to beta-adrenergic receptors. J Biol Chem 269:21519-25
Popova, J S; Johnson, G L; Rasenick, M M (1994) Chimeric G alpha s/G alpha i2 proteins define domains on G alpha s that interact with tubulin for beta-adrenergic activation of adenylyl cyclase. J Biol Chem 269:21748-54
Roychowdhury, S; Rasenick, M M (1994) Tubulin-G protein association stabilizes GTP binding and activates GTPase: cytoskeletal participation in neuronal signal transduction. Biochemistry 33:9800-5
Roychowdhury, S; Wang, N; Rasenick, M M (1993) G protein binding and G protein activation by nucleotide transfer involve distinct domains on tubulin: regulation of signal transduction by cytoskeletal elements. Biochemistry 32:4955-61
Lazarevic, M B; Yan, K; Swedler, W I et al. (1992) Effect of gold compounds on the activity of adenylyl cyclase in human lymphocyte membranes. Arthritis Rheum 35:857-64
Wang, N; Rasenick, M M (1991) Tubulin-G protein interactions involve microtubule polymerization domains. Biochemistry 30:10957-65
Ozawa, H; Rasenick, M M (1991) Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem 56:330-8

Showing the most recent 10 out of 16 publications